Marker Therapeutics Inc. Company Profile
NASDAQ: MRKRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.95-0.09 (-8.65%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Marker Therapeutics at a glance
Marker Therapeutics Inc. (NASDAQ: MRKR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. At a market capitalization of $17.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001094038, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Marker Therapeutics Inc.
- Ticker
- NASDAQ: MRKR
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- Market cap
- $17.34M
- SEC CIK
- 0001094038
Companies similar to Marker Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NCELNewcelX Ltd. | 3.11 | +2.47% | $17.96M | vs MRKR |
| NEUPNeuphoria Therapeutics Inc. | 3.35 | -2.05% | $18.13M | vs MRKR |
| ACTUActuate Therapeutics Inc. | 0.679 | -6.24% | $16.31M | vs MRKR |
| RADXRadiopharm Theranostics Limited ADR | 1.11 | -3.48% | $16.20M | vs MRKR |
| AKTXAkari Therapeutics plc ADS | 8.13 | -5.74% | $18.58M | vs MRKR |
| RKTORocket One Inc. | 0.6461 | -3.57% | $16.09M | vs MRKR |
| PTNPalatin Technologies Inc. | 9.01 | -5.36% | $16.05M | vs MRKR |
| LPCNLipocine Inc. | 1.93 | -12.27% | $15.91M | vs MRKR |